{"url_path":"/sec/inbs/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1725430/0001493152-26-022617-index.html","accession_number":"0001493152-26-022617","cik":"0001725430","ticker":"INBS","issuer_name":"INTELLIGENT BIO SOLUTIONS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1725430/0001493152-26-022617-index.html","primary_entity_key":"0001725430","primary_entity_name":"INTELLIGENT BIO SOLUTIONS INC."},"word_count":679,"has_tables":true,"body_markdown":"**ITEM\n6. EXHIBITS**\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n \n \n \n\n3.1\n \n[Certificate of Amendment to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Commission on December 12, 2025).](https://www.sec.gov/Archives/edgar/data/1725430/000149315225027534/ex3-1.htm)\n\n4.1\n \n[Form of Series K-1 Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Commission on January 2, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/ex4-1.htm)\n\n4.2\n \n[Form of Series K-2 Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the Commission on January 2, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/ex4-2.htm)\n\n4.3\n \n[Form of Series L Pre-Funded Warrant (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed with the Commission on January 2, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/ex4-3.htm)\n\n10.1\n \n[Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan (as amended October 16, 2025) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on October 21, 2025).](https://www.sec.gov/Archives/edgar/data/1725430/000149315225018806/ex10-1.htm)\n\n10.2\n \n[Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on January 2, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/ex10-1.htm)\n\n10.3\n \n[Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Commission on January 2, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/ex10-2.htm)\n\n10.4\n \n[Placement Agency Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the Commission on January 2, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/ex10-3.htm)\n\n10.5\n \n[2019 Long Term Incentive Plan Australian Sub-Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on March 23, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/ex10-1.htm)\n\n10.6\n \n[Form of AUS/UK Employee 2026 Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Commission on March 23, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/ex10-2.htm)\n\n10.7\n \n[Form of AUS/UK Employee 2026 Performance Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the Commission on March 23, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/ex10-3.htm)\n\n10.8\n \n[Form of AUS/UK Director 2026 Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the Commission on March 23, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/ex10-4.htm)\n\n10.9\n \n[Form of U.S. Employee 2026 Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed with the Commission on March 23, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/ex10-5.htm)\n\n10.10\n \n[Form of U.S. Employee 2026 Performance Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K filed with the Commission on March 23, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/ex10-6.htm)\n\n10.11\n \n[Form of U.S. Director 2026 Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K filed with the Commission on March 23, 2026).](https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/ex10-7.htm)\n\n31.1#\n \n[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm)\n\n31.2#\n \n[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm)\n\n32.1#\n \n[Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.](ex32-1.htm)\n\n32.2#\n \n[Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.](ex32-2.htm)\n\n101.INS#\n \nInline\nXBRL Instance Document.\n\n101.SCH#\n \nInline\nXBRL Taxonomy Extension Schema Document.\n\n101.CAL#\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEF#\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document.\n\n101.LAB#\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document.\n\n101.PRE#\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document.\n\n104#\n \nCover\nPage Interactive Data File (formatted in XBRL and included in Exhibit 101).\n\n \n\n#\nFiled herewith.\n\n \n\n30\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto\nduly authorized.\n\n \n\n \n \n**Intelligent\nBio Solutions Inc.**\n\n \n \n \n \n\nDate:\nMay\n13, 2026\nBy:\n*/s/\nHarry Simeonidis*\n\n \n \n \nHARRY\nSIMEONIDIS\n\n \n \n \nCHIEF\nEXECUTIVE OFFICER AND PRESIDENT\n\n \n \n \n(Principal\nExecutive Officer)\n\n \n \n \n \n\nDate:\nMay\n13, 2026\nBy:\n*/s/\nSpiro Sakiris*\n\n \n \n \nSPIRO\nSAKIRIS\n\n \n \n \nCHIEF\nFINANCIAL OFFICER\n\n \n \n \n(Principal\nFinancial Officer)\n\n \n\n31"}